Press release
GlowRow Named No. 2 Best Kayak Tour in the U.S. by USA Today, Beating Every Night Tour and All But One Daytime Operator
GlowRow Registered , the Texas-born experience brand transforming nighttime kayaking, has been named the #2 Best Kayak Tour in the U.S. by USA Today's 10 Best [https://10best.usatoday.com/awards/glowrow-rockport-little-bay-rockport-texas/] - ranking above every other nighttime and daytime kayak company in the nation except one.
GlowRow Registered was the only nighttime tour featured on the prestigious list and was outpaced only by a company with over 30 years in business. The kicker? GlowRow Registered is just three years old!
"We created something from nothing-no capital, no shortcuts. Just grit, innovation, and the desire to craft an unforgettable experience for adventurers," said founder Zack Jurasek. "This award proves what our guests already know-GlowRow Registered isn't just a tour. It's a moment you never forget."
Operating 11 core locations across Texas and 3 rotating special event destinations, GlowRow Registered offers fully guided nighttime kayaking experiences using crystal-clear boats illuminated by 20,000-lumen proprietary lighting systems and patented glowing paddles. Guests paddle through vibrant coastal ecosystems, casting light beneath and around them as they move-creating one of the most visually immersive outdoor adventures on the planet.
But GlowRow Registered isn't in the business of just tours or travel. GlowRow Registered sells transformation - the moment fear turns into fascination. It's the adrenaline of stepping into the unknown. It's the thrill of the dark giving way to something unforgettable. It's courage, wonder, and awe-made tangible in glowing water.
GlowRow Registered 's blend of innovation, immersive emotion, and fearless storytelling has earned it global recognition, media acclaim, and a fiercely loyal following.
Image: https://www.abnewswire.com/upload/2025/06/232629cc0178cbbb6f11ba495d81817b.jpg
GlowRow Registered At a Glance
1. #2 Best Kayak Tour in the U.S. - USA Today 10Best (2025)
1.1. Only nighttime kayak tour featured on the list
1.2. Outperformed every night tour and all but one daytime tour (30+ years old)
2. Innovative Experience of the Year (Global) - Travel & Hospitality Awards (2024/2025, UK)
3. Best of the Best Destination - North America - American Bus Association (ABA, 2023)
4. Experience of the Year - State of Texas Tourism Awards (2024)
5. Small Attraction of the Year - State of Texas Tourism Awards (2023)
6. Nominee - 2025 World Travel Awards - One of the highest recognitions in global tourism
"We don't just light up the night-we are the light that leads all others," said Zack Jurasek, founder of GlowRow Registered .
For inquiries email info@glowrow.com or call 361-746-325.
To learn more about GlowRow Registered , visit https://glowrow.com/
To make a booking visit: https://glowrow.com/book/
Image: https://www.abnewswire.com/upload/2025/06/421f078c4b3863239082f32ba7c20cda.jpg
Media Contact
Company Name: GlowRow
Contact Person: Zack Jurasek, Founder
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=glowrow-named-no-2-best-kayak-tour-in-the-us-by-usa-today-beating-every-night-tour-and-all-but-one-daytime-operator]
Phone: 361-746-325
State: Texas
Country: United States
Website: http://www.glowrow.com
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release GlowRow Named No. 2 Best Kayak Tour in the U.S. by USA Today, Beating Every Night Tour and All But One Daytime Operator here
News-ID: 4070933 • Views: …
More Releases from ABNewswire
Thymidine Kinase 2 Deficiency Market Insights: Unmet Needs and Emerging Therapie …
The Thymidine Kinase 2 deficiency (TK2d) market is poised for substantial growth in the coming decade, fueled by increasing awareness of this rare genetic disorder and the development of promising therapies like MT1621 (UCB).
DelveInsight's "Thymidine Kinase 2 Deficiency Market Insight, Epidemiology and Market Forecast - 2034 [https://www.delveinsight.com/report-store/thymidine-kinase-2-deficiency-tk2d-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr]" report delivers comprehensive insights into the current TK2d landscape and future market trends across the 7MM (United States, EU4, the United Kingdom, and…
Triple-Negative Breast Cancer Market Dynamics: Growth Rate, Key Players, Emergin …
The TNBC treatment market is poised for significant expansion, driven by the introduction of novel targeted therapies, immunotherapeutics, and antibody-drug conjugates by key players such as Merck, Roche, Gilead Sciences, AstraZeneca, Daiichi Sankyo, Seagen, Immunomedics, Novartis, BMS, Pfizer, and Eisai, among others.
DelveInsight's " [https://www.delveinsight.com/report-store/triple-negative-breast-cancer-tnbc-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr]" report delivers comprehensive insights into triple-negative breast cancer, including historical and forecasted epidemiology, current treatment paradigms, and emerging therapies across the 7MM (United States, EU4, United…
Non-Cystic Fibrosis Bronchiectasis Market Outlook 2034 - Clinical Trials, Market …
Non-Cystic Fibrosis Bronchiectasis companies working in the market are Insmed, AstraZeneca, Zambion, The Marcus Foundation, Inc., Chiesi Farmaceutici S.p.A., SolAeroMed Inc., Zambon SpA, Boehringer Ingelheim, Renovion, Inc., Novartis, Alaxia SAS, and others.
Non-Cystic Fibrosis Bronchiectasis Market Summary
The NCFB market in the 7MM was valued at ~USD 1,455 million in 2023 and is projected to expand at a CAGR of 14.5% (2024-2034), driven by innovative therapies such as brensocatib and CMS I-neb,…
Chronic Kidney Disease Market Outlook 2034 - Clinical Trials, Market Size, Medic …
Key Chronic Kidney Disease Companies are ProKidney, Reata Pharmaceuticals, Inc., Novo Nordisk A/S, Boehringer Ingelheim, Eli Lilly and Company, KBP Biosciences, Kibow Pharma, Cincor Pharma, AstraZeneca, Allena Pharmaceuticals, DiaMedica Therapeutics Inc., Lexicon Pharmaceuticals, Sanofi, and others.
Chronic Kidney Disease Summary
The Chronic Kidney Disease (CKD) market in the United States was estimated at approximately USD 2,824 million in 2023 and is projected to demonstrate sustained growth throughout the forecast period. The US…
